Ethyl 3-cyclopropyl-3-hydroxypropanoate, 97%, 100g

2-(Piperazin-1-yl)quinoline, 95.0%, 500mg

2-(4-Bromo-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-propionic acid, 1g

Omipalisib, 99.93%, 50mg

8-Chloro-6-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyridin-3-amine, 98%, 25g

4-(4-Methylpent-3-en-1-yl)cyclohex-3-ene-1-carbaldehyde, 98% +(isomers mixture), 5g

Round bottom flask with standard ground joint 4000 ml NS 45/40

N-(4-Aminophenyl)-N-cyclopropyl-2-(dimethylamino)acetamide, 98%, 250mg

4-(2-Aminopyrimidin-5-yl)benzoic acid, 97.0%, 5g

3-Methyl-1-butene (ca. 16.5% in N,N-Dimethylformamide, ca. 2mol/L)100mL

(R)-(-)-1-Phenyl-1,2-ethanediol, 95.0%, 10g

tert-Butyl ((1R,3S)-3-aminocyclopentyl)carbamate, 95.0%, 5g

2-(3,5-Dinitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98+%, 250mg